Loading provider…
Loading provider…
Hematology & Oncology Physician in Boston, MA
NPI: 1457321861Primary Practice Location
BRIGHAM AND WOMEN'S HOSPITAL
75 Francis St, Boston, MA
Primary Employer
Binney Medical Associates
brighamandwomens.org
HQ Phone
Get MD Eric's Phone Numberphone_androidMobile
Get MD Eric's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 206 | 344 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 22 | 80 |
| 3 | 99442Physician telephone patient service, 11-20 minutes of medical discussion | 19 | 20 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 19 | 19 |
| 5 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 16 | 18 |
Authors: Aarti Asnani, Syed Mahmood, Ann Lacasce, James Januzzi, Bonnie Ky, Robb Friedman, Marielle Scherrer-Crosbie, Jeremy Abramson, Raymond Kwong, Austin Kim, Jacob Soumerai, Philippe Armand, Jakub Svoboda, Caron Jacobson, Ephraim Hochberg
Journal: JAMA
Authors: Steven Horwitz, Andrei Shustov, Radhakrishnan Ramchandren, John Leonard, Anne Beaven
Journal: J Clin Oncol
Publication Date: 2019-02-01
Lead Sponsor: Massachusetts General Hospital
Collaborators: Brigham and Women's Hospital, Dana-Farber Cancer Institute
Intervention / Treatment: DRUG: Placebo, DRUG: Atorvastatin
Lead Sponsor: Dana-Farber Cancer Institute
Collaborators: Celgene
Intervention / Treatment: DRUG: Lenalidomide
Lead Sponsor: Dana-Farber Cancer Institute
Intervention / Treatment: DRUG: Rituximab, DRUG: Pembrolizumab, BIOLOGICAL: Neo Vax